Citigroup, Elanco Animal Health And A Tech Stock: CNBC's 'Final Trades'
Citigroup, Elanco Animal Health And A Tech Stock: CNBC's 'Final Trades'
On June 27, Elanco Animal Health released updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia is a JAK Inhibitor that controls pruritus and atopic dermatitis in dogs. For Zenrelia, the FDA confirmed that all major technical sections (Effectiveness, Safety and Chemistry, Manufacturing, and Controls (CMC)) are complete as of late June.On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Citigroup Inc. (NYSE:C), which is scheduled to release earnings on Friday. "The market believes it's going to be good, so do I," he said.
在CNBC的“HalfTime Report Final Trades”上，Cerity Partners的Jim Lebenthal提到了花旗集團（NYSE:C），該公司計劃在週五發佈盈利報告。他說：“市場相信這將是好的，我也這麼認爲。”
Analysts expect Citigroup to report quarterly earnings at $1.41 per share, up from $1.33 per share in the year-ago period. The bank is projected to report revenue of $20.08 billion, compared to $19.44 billion in the year-earlier quarter.
分析師預計花旗集團的季度每股收益爲1.41美元，而去年同期爲1.33美元。該銀行的收入預計爲200.8億美元，而去年同期爲194.4億美元。
Stephanie Link of Hightower picked Elanco Animal Health Incorporated (NYSE:ELAN). "I like it on the buy because they have a lot of new products coming," she added.
Hightower的Stephanie Link選擇了Elanco Animal Health Incorporated（紐交所:ELAN）。她補充道：“我喜歡買它，因爲他們有很多新產品即將推出。”
On June 27, Elanco Animal Health released updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia is a JAK Inhibitor that controls pruritus and atopic dermatitis in dogs. For Zenrelia, the FDA confirmed that all major technical sections (Effectiveness, Safety and Chemistry, Manufacturing, and Controls (CMC)) are complete as of late June.
6月27日，Elanco Animal Health發佈了Zenrelia和Credelio Quattro預計獲得FDA批准的更新時間表。Zenrelia是一種JAk抑制劑，可控制犬的瘙癢和特應性皮炎。對於Zenrelia，FDA確認所有主要技術部分（有效性、安全性和化學、製造和控制（CMC））均已在6月底完成。
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
Joseph M. Terranova of Virtus Investment Partners named Corning Incorporated (NYSE:GLW) as his final trade.
Virtus Investment Partners的Joseph M. Terranova選擇了康寧公司（紐交所：GLW）作爲他的最後交易。
On Monday, Corning increased its second-quarter core sales guidance. The company now projects core sales to be approximately $3.6 billion (vs. consensus of $3.41 billion), an increase from the previous guidance of $3.4 billion. Core EPS is expected to reach the high end of, or slightly exceed, the management's guided range of 42 cents to 46 cents (vs. estimate of 45 cents).
週一，康寧公司增加了其第二季度核心銷售指導。該公司現預計核心銷售額爲約36億美元（相比預估的34.1億美元），這是從先前的34億美元的指導值增加的。核心每股收益預計將達到管理層指導範圍42美分至46美分的高端，或略微超過（預估爲45美分）。
Price Action:
價格行動：
- Citigroup shares gained 1.1% to close at $64.74 on Monday.
- Elanco Animal Health fell 2% to settle at $13.94 during Monday's session.
- Corning shares gained 12% to close at $43.05 during Monday's session.
- 週一，花旗集團股價上漲1.1％，收於64.74美元。
- 週一，Elanco Animal Health股價下跌2％，收於13.94美元。
- 週一，康寧公司股價上漲了12％，收於43.05美元。
- Wall Street's Most Accurate Analysts Say Buy These 3 Utilities Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師表示，應該買入這3只公用事業股票，可提供高股息收益。
Image created using artificial intelligence via Midjourney.
圖像由Midjourney通過人工智能創建。
